We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
Cap. Flow
+$210M
Cap. Flow %
5.36%
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557

Sector Composition

Rank Sector Weight
1 Financials 9.4%
2 Technology 6.32%
3 Consumer Discretionary 5.14%
4 Industrials 4.27%
5 Communication Services 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBER
1426
DELISTED
Ibere Pharmaceuticals
IBER
$133K ﹤0.01%
13,634
+3,634
+36% +$35.1K
CYCN icon
1427
Cyclerion Therapeutics
CYCN
$16.8M
$131K ﹤0.01%
2,127
-378
-15% -$24.7K
TAST
1428
DELISTED
Carrols Restaurant Group, Inc.
TAST
$131K ﹤0.01%
35,800
BGSX.U
1429
DELISTED
Build Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
BGSX.U
$131K ﹤0.01%
+13,128
New +$131K
BB icon
1430
CALL
BlackBerry
BB
$5.18B
$130K ﹤0.01%
13,400
+2,600
+24% +$27.3K
BRY
1431
DELISTED
Berry Corp
BRY
$130K ﹤0.01%
+17,994
New +$106K
PAYO icon
1432
CALL
Payoneer
PAYO
$2.4B
$130K ﹤0.01%
+15,200
New +$148K
FLL icon
1433
Full House Resorts
FLL
$90.5M
$129K ﹤0.01%
+12,174
New +$104K
JCICU
1434
DELISTED
Jack Creek Investment Corp. Units
JCICU
$128K ﹤0.01%
+12,719
New +$127K
FOLD
1435
DELISTED
Amicus Therapeutics
FOLD
$127K ﹤0.01%
13,300
ITHXU
1436
DELISTED
ITHAX Acquisition Corp. Unit
ITHXU
$127K ﹤0.01%
+12,752
New +$127K
TPGS
1437
DELISTED
TPG Pace Solutions Corp.
TPGS
$126K ﹤0.01%
12,500
SPTK
1438
DELISTED
SportsTek Acquisition Corp. Class A Common Stock
SPTK
$125K ﹤0.01%
+12,686
New +$123K
DKDCU
1439
DELISTED
Data Knights Acquisition Corp. Unit
DKDCU
$124K ﹤0.01%
11,950
-600
-5% -$6.27K
MVLAW
1440
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$123K ﹤0.01%
130,000
KPTI icon
1441
Karyopharm Therapeutics
KPTI
$44.4M
$122K ﹤0.01%
1,400
RKTA
1442
DELISTED
Rocket Internet Growth Opportunities Corp.
RKTA
$121K ﹤0.01%
+12,273
New +$119K
BSKYW
1443
DELISTED
Big Sky Growth Partners, Inc. Warrant
BSKYW
$120K ﹤0.01%
+150,000
New +$161K
ICU icon
1444
SeaStar Medical
ICU
$14.7M
$117K ﹤0.01%
47
-11
-19% -$27.3K
EOCW.WS
1445
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$116K ﹤0.01%
+105,225
New +$112K
VYGG
1446
DELISTED
Vy Global Growth
VYGG
$116K ﹤0.01%
+11,569
New +$114K
BLUA.U
1447
DELISTED
BlueRiver Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary shares
BLUA.U
$115K ﹤0.01%
+11,510
New +$114K
MCAER
1448
DELISTED
Mountain Crest Acquisition Corp. III Right
MCAER
$113K ﹤0.01%
+225,000
New +$127K
SIRI icon
1449
SiriusXM
SIRI
$9.7B
$112K ﹤0.01%
+1,831
New +$115K
NXU.U
1450
DELISTED
Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi
NXU.U
$112K ﹤0.01%
+10,903
New +$110K

Similar funds

Prelude Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.

  • Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
  • Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
  • Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
  • Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
  • Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
  • Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.